AFTER two consecutive record-breaking years at the domestic box office, 2017 was the year the momentum slowed—even with the late adrenaline boost of a new “Star Wars” film.
When all is said and done on Jan. 1, the domestic box office is estimated to net out with $11.1 billion in grosses, down around 2.6 percent from 2016’s $11.4 billion, according to projections from box office tracker comScore. Looked at another way, it’s also likely to be the third highest grossing year in cinema history.
Experts and insiders are somewhat divided on what this might mean for the current state and future of movie going and whether it is reason for alarm or just part of the natural ebb and flow of business. But one thing remains clear to all parties: Quality rules. If the movies are good, audiences will turn out. If they’re not, they won’t.
“2017 was the tale of two cities. The year started really big. January to April were smash successes and September, November and December are huge successes, but the middle of the year ... markedly underperformed. It’s really opened up an intriguing argument between people who think the movie business is challenged and people who think the movie business just needs for Hollywood to make appealing movies,” said Adam Aron, chief executive officer of AMC, the largest movie theater chain in the US. “We think the record of 2017 demonstrates that when Hollywood makes good movies, America goes to see those movies.”
For the second year in a row, the Walt Disney Company is at the top of the ladder with over $2.2 billion in domestic revenue making up over 21.2 percent of the market share from releases like “The Last Jedi,” “Beauty and the Beast” and “Guardians of the Galaxy Vol. 2” ($389.8 million).
Warner Bros. followed in second with 18.9 percent of the market share, and over $2 billion thanks to films like “Wonder Woman,” “It,” “Dunkirk” and even “Justice League,” which underperformed domestically with $223.2 million. The studio also had its best worldwide year ever with around $5 billion in grosses. Universal took third with around $1.5 billion compliments of
“Despicable Me 3” ($264.6 million), “The Fate of the Furious” ($225.8 million) and “Get Out.”
Quality content on streaming platforms like Netflix and Amazon and premium cable options like HBO continue to be formidable draws for consumer attention too.
“As an industry we have some really big challenges ahead of us, which involves vying for the consumer’s time,” said Jeff Goldstein, Warner Bros.’ president of domestic distribution. “It’s more competitive today than it ever has been before.”
Jeff Bock, a senior box office analyst for Exhibitor Relations, says movies can’t compete.
“2017 will ultimately be remembered as the changing of the guard where people realized, you know what, movies aren’t getting better, but TV is,” said Bock, who notes that for about the same price as a movie ticket, a consumer can get access to all the content on a streaming service and its proprietary content (like Netflix’s “Stranger Things” or “The Crown”).
AMC’s Aron, a self-proclaimed fan of “The Crown,” thinks there is room for both, however, and is continuing to invest in upgraded theatrical experiences for audiences—from better seats to premium food and drink options.
“The movie business in the United States is going to sell a billion tickets this year. That’s 55 times the attendance of all 32 teams in the National Football League
put together,” Aron said. “Last I checked, Netflix and Amazon were in business last year, and last year was the biggest in the history of film.”
“Streaming is not going to kill the movies,” said Paul Dergarabedian, comScore’s senior media analyst. “It’s just a wake-up call for an industry that really has not changed the way movies have been marketed. The usual formulas for success don’t seem to work anymore.” (AP )
Published in the SunStar Cebu newspaper on January 01, 2018.
Latest issues of SunStar Cebu also available on your mobile phones, laptops, and tablets. Subscribe to our digital editions at epaper.sunstar.com.ph and get a free seven-day trial.